查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1968102

全球滅菌檢測市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Sterility Testing Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 173 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計滅菌檢測市場將從 2025 年的 25.8 億美元成長到 2034 年的 51.1 億美元，2026 年至 2034 年的複合年成長率為 7.89%。

全球無菌檢測市場正隨著生物製藥產量的成長以及藥品和醫療設備安全法規日益嚴格的擴張。無菌注射劑和先進治療方法的產量不斷增加，使得市場對檢驗的無菌檢測方法的依賴性日益增強。傳統的培養為基礎的檢測方法和快速微生物檢測方法均推動了市場收入的穩定成長。

關鍵促進因素包括嚴格的全球合規標準、GMP認證設施的擴張以及對更短產品放行週期的需求。能夠在縮短檢測週期的同時保持準確性的快速微生物檢測方法正日益受到關注。滅菌檢測服務外包的增加以及自動化檢測系統的應用進一步推動了市場成長。

展望未來，數位化品管系統和即時污染監測的整合將塑造未來的發展趨勢。監管機構對檢驗的快速檢測平台的支援將加速其應用。對無菌生物製藥生產和個人化醫療的持續投資有望維持長期成長機會。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球滅菌檢測市場：依產品類型分類

  • 市場分析、洞察與預測
  • 裝置
  • 試劑盒和試劑
  • 服務

第5章 全球滅菌檢測市場：依檢測類型分類

  • 市場分析、洞察與預測
  • 薄膜過濾
  • 直接接種法
  • 其他無菌試驗

第6章 全球滅菌檢測市場：依應用領域分類

  • 市場分析、洞察與預測
  • 藥品和生物製藥生產
  • 醫療設備製造
  • 其他用途

第7章 全球滅菌檢測市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 製藥公司
  • 生技公司
  • 醫療設備製造商
  • 受託研究機構
  • 其他

第8章 全球滅菌檢測市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Charles River Laboratories International Inc
    • Merck KGaA
    • SGS SA
    • WuXi AppTec
    • BioMAfA（C）Rieux SA
    • Thermo Fisher Scientific Inc
    • Pace Analytical Services LLC
    • Nelson Laboratories LLC
    • Toxikon Corporation
    • Sartorius AG
    • Eurofins Scientific
    • Boston Analytical
    • Pacific BioLabs
    • Steris PLC
    • Microbac Laboratories Inc
簡介目錄
Product Code: VMR112110213

The Sterility Testing Market size is expected to reach USD 5.11 Billion in 2034 from USD 2.58 Billion (2025) growing at a CAGR of 7.89% during 2026-2034.

The Global Sterility Testing market is expanding in response to rising biologics production and stricter regulatory requirements for pharmaceutical and medical device safety. Growing manufacturing of sterile injectables and advanced therapies has increased reliance on validated sterility assurance methods. Both traditional culture-based testing and rapid microbiological methods are contributing to steady market revenue growth.

Primary drivers include stringent global compliance standards, expansion of GMP-certified facilities, and demand for faster product release timelines. Rapid microbiological methods that reduce testing duration while maintaining accuracy are gaining traction. Increased outsourcing of sterility testing services and adoption of automated detection systems further enhance market momentum.

Looking forward, the integration of digital quality management systems and real-time contamination monitoring will shape future advancements. Regulatory support for validated rapid testing platforms will accelerate adoption. Continued investment in sterile biologic manufacturing and personalized medicine will sustain long-term growth opportunities.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

  • Instruments
  • Kits & Reagents
  • Services

By Test Type

  • Membrane Filtration
  • Direct Inoculation
  • Other Sterility Tests

By Application

  • Pharmaceutical & Biological Manufacturing
  • Medical Devices Manufacturing
  • Other Applications

By End-User

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Medical Device Manufacturers
  • Contract Research Organizations
  • Others

COMPANIES PROFILED

  • Charles River Laboratories International Inc, Merck KGaA, SGS SA, WuXi AppTec, bioMrieux SA, Thermo Fisher Scientific Inc, Pace Analytical Services LLC, Nelson Laboratories LLC, Toxikon Corporation, Sartorius AG, Eurofins Scientific, Boston Analytical, Pacific BioLabs, Steris PLC, Microbac Laboratories Inc
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL STERILITY TESTING MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product Type
  • 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Kits & Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL STERILITY TESTING MARKET: BY TEST TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Test Type
  • 5.2. Membrane Filtration Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Direct Inoculation Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Other Sterility Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL STERILITY TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Pharmaceutical & Biological Manufacturing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Medical Devices Manufacturing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL STERILITY TESTING MARKET: BY END-USER 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End-user
  • 7.2. Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Medical Device Manufacturers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL STERILITY TESTING MARKET: BY REGION 2022-2034(USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Product Type
    • 8.2.2 By Test Type
    • 8.2.3 By Application
    • 8.2.4 By End-user
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Product Type
    • 8.3.2 By Test Type
    • 8.3.3 By Application
    • 8.3.4 By End-user
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Product Type
    • 8.4.2 By Test Type
    • 8.4.3 By Application
    • 8.4.4 By End-user
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Product Type
    • 8.5.2 By Test Type
    • 8.5.3 By Application
    • 8.5.4 By End-user
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 South East Asia
    • 8.5.10 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Product Type
    • 8.6.2 By Test Type
    • 8.6.3 By Application
    • 8.6.4 By End-user
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL STERILITY TESTING INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Charles River Laboratories International Inc
    • 10.2.2 Merck KGaA
    • 10.2.3 SGS S.A
    • 10.2.4 WuXi AppTec
    • 10.2.5 BioMAfA(C)Rieux SA
    • 10.2.6 Thermo Fisher Scientific Inc
    • 10.2.7 Pace Analytical Services LLC
    • 10.2.8 Nelson Laboratories LLC
    • 10.2.9 Toxikon Corporation
    • 10.2.10 Sartorius AG
    • 10.2.11 Eurofins Scientific
    • 10.2.12 Boston Analytical
    • 10.2.13 Pacific BioLabs
    • 10.2.14 Steris PLC
    • 10.2.15 Microbac Laboratories Inc